User Experience of an Innovative Mobile Health Program to Assist in Insulin Dose Adjustment: Outcomes of a Proof-Of-Concept Trial

Abstract

The m-Health system for IDA showed promising levels of adherence, usability, perception of usefulness, and satisfaction. Further research is required to assess the feasibility and cost-effectiveness of using this system in outpatient settings.

Outcomes of a feasibility trial using an innovative mobile health programme to assist in insulin dose adjustment

“…In this feasibility trial, we evaluated the time-efficiencies and user experience of a newly developed mIDA service, following promising user feedback from an earlier proof-of-concept trial 11. The findings suggest that mIDA improves time-efficiencies by 54.8% from a CDE perspective, has the potential to reduce transcription error and improves the patient experience in the IDA service.…”

“…We did not report on adherence as it would be impossible to differentiate between the two approaches given a within-subject design. mHealth intervention trials have shown that the users improve glycaemic status in the short-term (up to 12 months)20 but reports regarding adherence are mixed and difficult to evaluate 11 21. As the IDA process usually lasts for a period of 4–6 weeks only, the service efficiency derived from mHealth strategies are likely to be sustainable.…”

“…The MDMS was developed through an iterative process with the aim to enhance the quality and timeliness of the patient–clinician interaction, and support patient self-management of diabetes. The earlier mIDA proof-of-concept study showed promising levels of adherence, usability, perception of usefulness and satisfaction 11. The study participants provided feedback to improve the MDMS.…”

“…We designed a mobile-based IDA (mIDA) programme to improve the efficiency of the IDA service, improve the patient experience and reduce the possibility of transcription errors. We previously tested and reported on the mIDA programme through a proof-of-concept trial involving patients with diabetes and stable glycaemic control 11. The mIDA uses the mobile diabetes management system (MDMS) comprising a smartphone app (android version for this trial) which pairs with a Bluetooth-enabled glucose meter and automatically uploads blood glucose levels (BGLs) to a clinician portal via the ‘internet cloud’ (figure 1).…”

Tecnologia de reabilitação no cuidado do diabetes mellitus: desenvolvimento e validação de um software que personaliza a evolução de exercícios para pés e tornozelos

“…Para a temática DM também é possível encontrar alguns usos do e-health como por exemplo um medidor de glicose ativado por bluetooth para ajudar no ajuste diário de dose de insulina, apresentando índices satisfatórios de adesão e usabilidade pelos usuários (Ding et al, 2017). Ou até mesmo um telemonitoramento utilizado para controlar a glicemia das pessoas com diabetes.…”